Rajesh K. Malik
Directeur Technique/Scientifique/R&D chez G1 THERAPEUTICS, INC.
Fortune : 259 824 $ au 30/04/2024
Postes actifs de Rajesh K. Malik
Sociétés | Poste | Début | Fin |
---|---|---|---|
G1 THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/07/2014 | - |
Meryx, Inc.
Meryx, Inc. Pharmaceuticals: MajorHealth Technology Meryx, Inc. operates as an immune-oncology company. It focuses on developing drugs that inhibit tumor growth and initiate anti-tumor immunity in a range of cancer, such as leukemia, lung cancer, and melanoma. The company was founded by Doug Graham, Shelley Earp, and Stephen Frye in 2007 and is headquartered in Chapel Hill, NC. | Directeur/Membre du Conseil | 01/05/2018 | - |
Historique de carrière de Rajesh K. Malik
Anciens postes connus de Rajesh K. Malik
Sociétés | Poste | Début | Fin |
---|---|---|---|
POIT BIOP | Directeur/Membre du Conseil | 30/06/2021 | 27/12/2023 |
Independent Dir/Board Member | 30/06/2021 | 27/12/2023 | |
AGENNIX AG | Directeur/Membre du Conseil | 01/01/2007 | 01/01/2013 |
Directeur Technique/Scientifique/R&D | 01/01/2007 | 01/01/2013 | |
FENNEC PHARMACEUTICALS INC. | Directeur Technique/Scientifique/R&D | 01/09/2004 | 01/01/2007 |
EMD Pharmaceuticals, Inc.
EMD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, EMD Pharmaceuticals, Inc. is a company that manufactures pharmaceutical preparations. The company is based in Durham, NC. The company was founded by Nancy J. Wysenski. | Directeur/Membre du Conseil | 01/01/2002 | 01/01/2004 |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/2000 | 01/01/2002 |
University of Virginia | Corporate Officer/Principal | - | - |
Agennix, Inc.
Agennix, Inc. Pharmaceuticals: MajorHealth Technology Agennix, Inc. develops drugs for the treatment of cancer and wound healing. It develops liquid formulation of talactoferrin for cancer indications and a topical gel formulation for the treatment of diabetic foot ulcers. The company is headquartered in Houston, TX. | Directeur Technique/Scientifique/R&D | 01/01/2007 | - |
Formation de Rajesh K. Malik
University of Sheffield Medical School | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 9 |
Allemagne | 2 |
Royaume-Uni | 2 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 4 |
Director/Board Member | 4 |
Corporate Officer/Principal | 2 |
Sectorielle
Health Technology | 9 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 4 |
---|---|
FENNEC PHARMACEUTICALS INC. | Health Technology |
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
G1 THERAPEUTICS, INC. | Health Technology |
POIT BIOP | Health Technology |
Entreprise privées | 4 |
---|---|
Agennix, Inc.
Agennix, Inc. Pharmaceuticals: MajorHealth Technology Agennix, Inc. develops drugs for the treatment of cancer and wound healing. It develops liquid formulation of talactoferrin for cancer indications and a topical gel formulation for the treatment of diabetic foot ulcers. The company is headquartered in Houston, TX. | Health Technology |
EMD Pharmaceuticals, Inc.
EMD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, EMD Pharmaceuticals, Inc. is a company that manufactures pharmaceutical preparations. The company is based in Durham, NC. The company was founded by Nancy J. Wysenski. | Health Technology |
Agennix AG
Agennix AG BiotechnologyHealth Technology Agennix AG was a pharmaceutical company, which engaged in the development of protein-based drugs for oncology, asthma and wound healing. Its clinical development programs included oral talactoferrin alfa and RGB-286638. The company was founded in 1993 and was headquartered in Heidelberg, Germany. | Health Technology |
Meryx, Inc.
Meryx, Inc. Pharmaceuticals: MajorHealth Technology Meryx, Inc. operates as an immune-oncology company. It focuses on developing drugs that inhibit tumor growth and initiate anti-tumor immunity in a range of cancer, such as leukemia, lung cancer, and melanoma. The company was founded by Doug Graham, Shelley Earp, and Stephen Frye in 2007 and is headquartered in Chapel Hill, NC. | Health Technology |
- Bourse
- Insiders
- Rajesh K. Malik
- Expérience